Jun Liu, Qinghua Ren, Siqi Li, Lingling Zheng, Xu Yang, Xianyu Zhu et al. 18F-FDG PET/CT-based Metabolic-clinical prognostic model could refine risk stratification in high-risk neuroblastoma. // BMC Medical Imaging. – 2026. – DOI: 10.1186/s12880-026-02669-6. – URL: https://doi.org/10.1186/s12880-026-02669-6
Jun Liu, Qinghua Ren, Siqi Li, Lingling Zheng, Xu Yang, Xianyu Zhu, Mingyu Zhang, Jiayu Sun, Jie Liu, Huanmin Wang, Jigang Yang, & Wei Wang (2026). 18F-FDG PET/CT-based Metabolic-clinical prognostic model could refine risk stratification in high-risk neuroblastoma. BMC Medical Imaging. https://doi.org/10.1186/s12880-026-02669-6
Jun Liu, et al. “18F-FDG PET/CT-based Metabolic-clinical prognostic model could refine risk stratification in high-risk neuroblastoma.” BMC Medical Imaging, 2026. doi:10.1186/s12880-026-02669-6.
@article{Liu2026,
title = {18F-FDG PET/CT-based Metabolic-clinical prognostic model could refine risk stratification in high-risk neuroblastoma},
author = {Liu, Jun and Ren, Qinghua and Li, Siqi and Zheng, Lingling and Yang, Xu and Zhu, Xianyu and Zhang, Mingyu and Sun, Jiayu and Liu, Jie and Wang, Huanmin and Yang, Jigang and Wang, Wei},
journal = {BMC Medical Imaging},
year = {2026},
doi = {10.1186/s12880-026-02669-6},
url = {https://doi.org/10.1186/s12880-026-02669-6}
}